search
Back to results

Anesthetic to Reduce Dysphagia After Anterior Cervical Discectomy and Fusion Surgery

Primary Purpose

Dysphagia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
bupivacaine hydrochloride 0.5% solution
0.9% NaCl solution
Sponsored by
Justin Parker Neurological Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Dysphagia focused on measuring Anterior Cervical Discectomy and Fusion, Dysphagia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients older than 18 y.o.
  • Patients undergoing one- or two-level anterior cervical discectomy and fusion surgery for radiculopathy or myelopathy symptoms
  • Patients are wiling and able to sign informed consent and complete questionnaires

Exclusion Criteria:

  • More than 2-level ACDF surgeries
  • Previous cervical spine surgery
  • Surgeries for trauma, infection or tumor
  • Known hypersensitivity reactions to bupivacaine hydrochloride or other amino-amide anesthetics (e.g. lidocaine)
  • Known history of swallowing issues (e.g. dysphagia, odynophagia)
  • Pregnant or breastfeeding

Sites / Locations

  • Boulder Neurosurgical Associates

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

bupivacaine hydrochloride 0.5% solution

0.9% NaCl solution

Arm Description

Bupivacaine hydrochloride 0.5% 10 mL solution poured into the retropharyngeal space intraoperatively before wound closure during anterior cervical discectomy and fusion procedure

0.9% NaCl 10 mL solution poured into the retropharyngeal space intraoperatively before wound closureduring anterior cervical discectomy and fusion procedure

Outcomes

Primary Outcome Measures

Reduction in dysphagia scores
Swallowing-Quality of Life Questionnaire

Secondary Outcome Measures

Full Information

First Posted
February 17, 2015
Last Updated
February 11, 2020
Sponsor
Justin Parker Neurological Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT02376205
Brief Title
Anesthetic to Reduce Dysphagia After Anterior Cervical Discectomy and Fusion Surgery
Official Title
The Effectiveness of Postoperative Local Retropharyngeal Space Anesthetic to Reduce Dysphagia After Anterior Cervical Discectomy and Fusion Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
February 2015 (Actual)
Primary Completion Date
March 11, 2019 (Actual)
Study Completion Date
March 11, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Justin Parker Neurological Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The main objective of this study is to analyze the effects of local anesthetic application into the retropharyngeal space and its ability to reduce dysphagia symptoms and/or occurrence rates in patients undergoing anterior cervical discectomy and fusion.
Detailed Description
The patients will be randomly assigned into one of the two groups to receive either bupivacaine hydrochloride 0.5% solution if they are randomized to the treatment group or 0.9% NaCl solution if they are randomized to the control group. These solutions will be poured into the retropharyngeal space intraoperatively before wound closure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dysphagia
Keywords
Anterior Cervical Discectomy and Fusion, Dysphagia

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
150 (Actual)

8. Arms, Groups, and Interventions

Arm Title
bupivacaine hydrochloride 0.5% solution
Arm Type
Experimental
Arm Description
Bupivacaine hydrochloride 0.5% 10 mL solution poured into the retropharyngeal space intraoperatively before wound closure during anterior cervical discectomy and fusion procedure
Arm Title
0.9% NaCl solution
Arm Type
Placebo Comparator
Arm Description
0.9% NaCl 10 mL solution poured into the retropharyngeal space intraoperatively before wound closureduring anterior cervical discectomy and fusion procedure
Intervention Type
Drug
Intervention Name(s)
bupivacaine hydrochloride 0.5% solution
Other Intervention Name(s)
Marcaine
Intervention Description
10mL will be poured into the retropharyngeal space intraoperatively during anterior cervical discectomy and fusion procedure
Intervention Type
Drug
Intervention Name(s)
0.9% NaCl solution
Other Intervention Name(s)
Saline
Intervention Description
10mL will be poured into the retropharyngeal space intraoperatively during anterior cervical discectomy and fusion procedure
Primary Outcome Measure Information:
Title
Reduction in dysphagia scores
Description
Swallowing-Quality of Life Questionnaire
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients older than 18 y.o. Patients undergoing one- or two-level anterior cervical discectomy and fusion surgery for radiculopathy or myelopathy symptoms Patients are wiling and able to sign informed consent and complete questionnaires Exclusion Criteria: More than 2-level ACDF surgeries Previous cervical spine surgery Surgeries for trauma, infection or tumor Known hypersensitivity reactions to bupivacaine hydrochloride or other amino-amide anesthetics (e.g. lidocaine) Known history of swallowing issues (e.g. dysphagia, odynophagia) Pregnant or breastfeeding
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alexander Mason, MD
Organizational Affiliation
Boulder Neurosurgical Associates
Official's Role
Principal Investigator
Facility Information:
Facility Name
Boulder Neurosurgical Associates
City
Boulder
State/Province
Colorado
ZIP/Postal Code
80303
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Anesthetic to Reduce Dysphagia After Anterior Cervical Discectomy and Fusion Surgery

We'll reach out to this number within 24 hrs